|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| A61K 47/50 | |||
| A61K 47/69 | |||
| A61P 3/06 |
| (11) | Number of the document | 3125921 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15710087.6 |
| Date of filing the European patent application | 2015-03-09 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/019362 |
| Date | 2015-03-09 |
| (87) | Number | WO 2015/138278 |
| Date | 2015-09-17 |
| (30) | Number | Date | Country code |
| 201461950960 P | 2014-03-11 | US |
| (72) |
DIENER, John Louis, US
GAO, Jiaping, US
SCHIEBINGER, Rick Jerome, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | FGF21 VARIANTS FOR USE IN TREATING HIV-HAART INDUCED PARTIAL LIPODYSTROPHY |
| FGF21 VARIANTS FOR USE IN TREATING HIV-HAART INDUCED PARTIAL LIPODYSTROPHY |